Sentence examples for malignant profile from inspiring English sources
This could be related to the high homogeneity in the expression profiles of the FTC samples, which were positive for the PAX8-PPARG rearrangement and significantly related to the malignant profile of the PTC samples.
Due to low prevalence a larger cohort is needed to examine the malignant profile of OSF.
We currently employed TUNEL staining in salivary tumours for evaluation of their malignant profile as TUNEL examination has often been performed by investigators in other cancer types and in view of the fact that an unbalanced admixture of proliferative cells and apoptotic cells in neoplastic parenchyma is related to tumour growth.
Clustering of non-malignant profiles revealed three clusters that were significantly different in smoking status composition.
A Fisher's Exact test and Chi-square tests were performed to assess the distribution of tumor and non-malignant profiles, and distribution of the three smoking types within the identified clusters, respectively.
The TCGA, which represents the largest public repository for LUAC miRNA expression data generated by sequencing, contains a small number of NST (n = 16) and few patient-matched LUAC tumor and non-malignant profiles.
Smaller breast lesions will have the problem that the measured lesion Cho levels are reduced by partial volume effects, reducing the changes of being able to demonstrate a malignant Cho profile.
Moreover, the neuroblastoma transcriptome and proteome are dramatically altered by hypoxia toward malignant and metastatic profiles.
The absolute level of IFNAR mRNAs ranges wildly due to inter-individual variations and is not related to their malignant and metastatic profiles.
The absolute level of IFNAR1 and IFNAR2 mRNAs in tumor and non-tumor tissues did not correlate with the malignant and metastatic profiles.
To evaluate the differential estrogen metabolism between benign and malignant PTCs, estrogen profiling by gas chromatography mass spectrometry was applied to urine samples from postmenopausal patients with 9 benign tumors and 18 malignant stage I and III/IV PTCs.
